| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |